Drugs Health Pharma

Merck meets main goal during end-stage trial of HPV vaccine in Japan

Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in

Read More
Drugs Health Pharma

Endocrine-disrupting chemicals may trigger early puberty in girls

Exposure to certain endocrine-disrupting chemicals, especially musk ambrette, may trigger early puberty in girls, a study by the National Institutes of Health finds.

Read More
Climate Drugs Medical

Namibia’s plan to cull elephants to feed drought-hit citizens draws ire

The Namibian government’s move to cull 83 elephants to feed its population to support its “drought relief” plan has invited the ire of

Read More
Drugs Health Medical

World’s first whole-eye and partial face transplant recipient is doing well

HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well

Read More
Climate Health Medical

Metabolic profiling may help prevent SIDS, finds new research

HQ Team September 10, 2024: The exact cause of Sudden Infant Death Syndrome (SIDS), also known as “cot death,” is still unknown. It

Read More
Drugs Health Pharma

GI tract damage may increase the risk of Parkinson’s disease by 76% 

People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing

Read More
Drugs Health Pharma

Sudan’s civil war is a ‘nightmare,’ WHO calls for urgent global action, aid

Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the

Read More
Drugs Health Pharma

EQT Private Capital Asia to acquire controlling stake in US-based GeBBS

EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to

Read More
Drugs Health Pharma

Summit’s lung cancer drug reduces risk of disease progression by 48%

Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,

Read More
Drugs Health Pharma

Young Indian male suspected to have mpox disease, contact tracing on

India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease,

Read More